Matches in Wikidata for { <http://www.wikidata.org/entity/Q80653295> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q80653295 description "article scientifique publié en 2008" @default.
- Q80653295 description "artículu científicu espublizáu en febreru de 2008" @default.
- Q80653295 description "scientific article published on 08 February 2008" @default.
- Q80653295 description "wetenschappelijk artikel" @default.
- Q80653295 description "наукова стаття, опублікована в лютому 2008" @default.
- Q80653295 name "Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships" @default.
- Q80653295 name "Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships" @default.
- Q80653295 type Item @default.
- Q80653295 label "Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships" @default.
- Q80653295 label "Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships" @default.
- Q80653295 prefLabel "Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships" @default.
- Q80653295 prefLabel "Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships" @default.
- Q80653295 P1433 Q80653295-19F950A1-4363-4840-897A-C6A5D90A4CB4 @default.
- Q80653295 P1476 Q80653295-EC152CD5-7819-43EB-AF83-CAF00650280A @default.
- Q80653295 P2093 Q80653295-47B0C8BB-C8E5-4801-B891-C108C8F227A7 @default.
- Q80653295 P2093 Q80653295-7E88B228-79A2-402E-839F-DCE548741F02 @default.
- Q80653295 P2093 Q80653295-9A4A5193-3740-4FFF-B721-06865289AA71 @default.
- Q80653295 P2093 Q80653295-AA508D75-3E5F-4987-844D-202FC3588A74 @default.
- Q80653295 P2093 Q80653295-AF2AF35C-3EEB-4FFF-8E4F-728446C9A01E @default.
- Q80653295 P2093 Q80653295-BC9F78C5-4F29-4955-9AC5-E2C3395A4E96 @default.
- Q80653295 P2093 Q80653295-E04E28A3-8005-4333-BB94-3A19741A10EA @default.
- Q80653295 P2860 Q80653295-CA123F4B-CA8D-4079-B6D7-072EA11EA254 @default.
- Q80653295 P304 Q80653295-3A8D592C-BFC5-481E-A262-043AB0B6855B @default.
- Q80653295 P31 Q80653295-95D1A9D7-0FB3-4D33-B57B-0D6503E9F41B @default.
- Q80653295 P356 Q80653295-1C198282-A09A-439A-8E4E-418484376F1E @default.
- Q80653295 P433 Q80653295-BE997BA4-EBCD-43F8-8FC4-C2BBB014C321 @default.
- Q80653295 P478 Q80653295-17A475A9-0C34-46B6-81CC-0E9070445A04 @default.
- Q80653295 P577 Q80653295-B9CB56C2-366D-461F-8298-099AC9066309 @default.
- Q80653295 P698 Q80653295-565C5E5E-E293-4D36-BCBB-2A3F8C26E841 @default.
- Q80653295 P356 JM070543K @default.
- Q80653295 P698 18257512 @default.
- Q80653295 P1433 Q900316 @default.
- Q80653295 P1476 "Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships" @default.
- Q80653295 P2093 "Bo Nordén" @default.
- Q80653295 P2093 "Brian Springthorpe" @default.
- Q80653295 P2093 "Igor Shamovsky" @default.
- Q80653295 P2093 "Klaus Urbahns" @default.
- Q80653295 P2093 "Laurent David" @default.
- Q80653295 P2093 "Stephen Connolly" @default.
- Q80653295 P2093 "Svetlana Ivanova" @default.
- Q80653295 P2860 Q34181050 @default.
- Q80653295 P304 "1162-1178" @default.
- Q80653295 P31 Q13442814 @default.
- Q80653295 P356 "10.1021/JM070543K" @default.
- Q80653295 P433 "5" @default.
- Q80653295 P478 "51" @default.
- Q80653295 P577 "2008-02-08T00:00:00Z" @default.
- Q80653295 P698 "18257512" @default.